Monthly olezarsen reduced triglycerides by 65% for people with severe hypertriglyceridemia, resulting in a greater than 85% ...

For adults with type 2 diabetes and/or overweight/obesity and high triglycerides, GLP-1RAs are not associated with pancreatitis.

There was an increase in the hepatic fat fraction, the long-term consequences of which are unknown, says Robert Rosenson.

Patients with severe hypertriglyceridemia have an increased risk of acute pancreatitis. The efficacy and safety of olezarsen, ...

The drug, given as a weekly subcutaneous injection, reduced both triglycerides and liver fat in the phase II trial.

An investigational triple agonist that targets fibroblast growth factor 21, glucagon and GLP-1 receptors cut triglyceride ...

During an AHA press conference, Li explained that each component of the triple-receptor agonist compensates for side effects ...

Triglycerides are fatty molecules composed of three fatty acids linked to a glycerol molecule and comprise up to 95% of the fats in our diet. After absorption, triglycerides are linked with protein ...

Dublin, March 04, 2025 (GLOBE NEWSWIRE) -- The "Hypertriglyceridemia - Pipeline Insight, 2025" clinical trials has been added to ResearchAndMarkets.com's offering. The "Hypertriglyceridemia - Pipeline ...

September 10, 2012 (Chevy Chase, Maryland) — Adults should be screened for high triglyceride levels once every five years because of the potential risk of cardiovascular disease and pancreatitis ...

A well-tolerated antisense oligonucleotide yielded significant reductions in severe hypertriglyceridemia while lowering risk for acute pancreatitis in two phase 3 trials.